☆ 4.7 Article

Inhibition of protein phosphatase 1 by inhibitor-2 exacerbates progression of cardiac failure in a model with pressure overload

CARDIOVASCULAR RESEARCH (2008)

Journal

CARDIOVASCULAR RESEARCH

Volume 79, Issue 3, Pages 464-471

Publisher

OXFORD UNIV PRESS

DOI: 10.1093/cvr/cvn113

Keywords

-

Categories

Cardiac & Cardiovascular Systems

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Immunology

Selective Inhibition of NLRP3 Inflammasome Reverses Pressure Overload-Induced Pathological Cardiac Remodeling by Attenuating Hypertrophy, Fibrosis, and Inflammation

Mengmeng Zhao, Jishou Zhang, Yao Xu, Jianfang Liu, Jing Ye, Zhen Wang, Di Ye, Yongqi Feng, Shuwan Xu, Wei Pan, Menglong Wang, Jun Wan

Summary: The study revealed that the NLRP3 inhibitor MCC950 could reverse cardiac remodeling induced by transverse aortic constriction (TAC), improving cardiac dysfunction, reducing cardiac hypertrophy and fibrosis, and decreasing inflammation and macrophage infiltration.

INTERNATIONAL IMMUNOPHARMACOLOGY (2021)

Add to Collection

Article Cell Biology

miR-21 upregulation exacerbates pressure overload-induced cardiac hypertrophy in aged hearts

Wei-Ting Chang, Jhih-Yuan Shih, Yu-Wen Lin, Tzu-Ling Huang, Zhih-Cherng Chen, Chi-Long Chen, Jan-Show Chu, Ping Yen Liu

Summary: This study reveals the association between miR-21 and pressure overload-induced cardiac remodeling in aged hearts. It suggests the potential therapeutic role of miR-21 in treating cardiac diseases in elderly individuals.

AGING-US (2022)

Add to Collection

Article Biochemistry & Molecular Biology

The Ablation of VEGFR-1 Signaling Promotes Pressure Overload-Induced Cardiac Dysfunction and Sudden Death

Annakaisa Tirronen, Nicholas L. Downes, Jenni Huusko, Johanna P. Laakkonen, Tomi Tuomainen, Pasi Tavi, Marja Hedman, Seppo Yla-Herttuala

Summary: Experimental studies have shown that VEGFR-1 signaling plays a crucial role in cardiac remodeling during pressure overload, and its deficiency leads to changes in LVH and increased risk of sudden death.

BIOMOLECULES (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Protective Effects of Thyroid Hormone Deprivation on Progression of Maladaptive Cardiac Hypertrophy and Heart Failure

Helena Kerp, Georg Sebastian Hoenes, Elen Tolstik, Judith Hoenes-Wendland, Janina Gassen, Lars Christian Moeller, Kristina Lorenz, Dagmar Fuehrer

Summary: Thyroid hormones are crucial for cardiac function, influencing heart rate and contractility, with altered levels associated with increased cardiovascular morbidity and mortality. This study found that restricting TH levels stopped maladaptive cardiac hypertrophy and improved function, while increased TH levels propelled maladaptive cardiac growth and heart failure development in mice with left ventricular pressure overload.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)

Add to Collection

Article Immunology

Inhibition of NK1.1 signaling attenuates pressure overload-induced heart failure, and consequent pulmonary inflammation and remodeling

Xiaochen He, Rui Xu, Lihong Pan, Umesh Bhattarai, Xiaoguang Liu, Heng Zeng, Jian-Xiong Chen, Michael E. Hall, Yingjie Chen

Summary: Inhibition of NK1.1 signaling effectively attenuates systolic overload-induced cardiac fibrosis, dysfunction, and consequent pulmonary remodeling in immunocompetent mice through modulating the cardiopulmonary inflammatory response.

FRONTIERS IN IMMUNOLOGY (2023)

Add to Collection

Article Plant Sciences

Lingguizhugan decoction dynamically regulates MAPKs and AKT signaling pathways to retrogress the pathological progression of cardiac hypertrophy to heart failure

Yao Chen, Lin Li, Cunyu Hu, Xin Zhao, Peng Zhang, Yanxu Chang, Ye Shang, Yafen Pang, Weiqiang Qian, Xianzhe Qiu, Hongxia Zhang, Deqin Zhang, Shukun Zhang, Yuhong Li

Summary: This study investigated the effects and mechanisms of Lingguizhugan decoction (LD) on heart failure (HF). The results showed that LD alleviated cardiac dysfunction by down-regulating CH-related genes and proteins expression, and the AKT and MAPKs signaling pathways were identified as potential targets for LD treatment. LD inhibited p38 and ERK phosphorylated expression levels, and its effects on the AKT-GSK3 beta/mTOR/P70S6K pathway varied at different time points. Additionally, bioactive compounds detected from plasma were predicted to be responsible for LD's effects on HF.

PHYTOMEDICINE (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Suppression of myeloid YAP antagonizes adverse cardiac remodeling during pressure overload stress

Jamie Francisco, Jin Guan, Yu Zhang, Yasuki Nakada, Satvik Mareedu, Eunah Sung, Che-Ming Hu, Shinichi Oka, Peiyong Zhai, Junichi Sadoshima, Dominic P. Del Re

Summary: Inflammation is a crucial factor in cardiovascular disease, and Yes-associated protein (YAP) has been found to play a key role in modulating inflammation in ischemic injury. This study investigated the role of YAP in non-ischemic cardiac inflammation. The results showed that YAP activation in myeloid cells contributes to cardiac inflammation and fibrosis during pressure overload stress. Inhibition of YAP may be a potential therapeutic target for non-ischemic heart disease.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2023)

Add to Collection

Article Medicine, Research & Experimental

Supression Thioredoxin reductase 3 exacerbates the progression of liver cirrhosis via activation of ferroptosis pathway

Qi Liu, Liming Xu, Guangming Ren, Jingzhuang Zhao, Yizhi Shao, Tongyan Lu

Summary: In the past decades, Txnrd3 has been found to be highly expressed in testis and involved in sperm maturation, but its role in liver diseases remains unclear. Iron is essential for humans and animals, but its overload can cause damage to various organs. The relationship between Txnrd3, iron, and cirrhosis is still not fully understood.

LIFE SCIENCES (2023)

Add to Collection

Article Chemistry, Multidisciplinary

Semaphorin3A Exacerbates Cardiac Microvascular Rarefaction in Pressure Overload-Induced Heart Disease

Chaofu Li, Yongchao Zhao, Fuhai Li, Zimu Wang, Zhimei Qiu, Yukun Yang, Weidong Xiong, Rui Wang, Han Chen, Fei Xu, Tongtong Zang, Zhiqiang Pei, Yan Wang, Bei Shi, Li Shen, Junbo Ge

Summary: Microvascular endothelial cells (MiVECs) impair angiogenic potential, leading to microvascular rarefaction, which is a characteristic feature of chronic pressure overload-induced cardiac dysfunction. Semaphorin3A (Sema3A), which is upregulated in MiVECs following angiotensin II (Ang II) activation and pressure overload stimuli, plays a key role in pressure overload-induced microvascular rarefaction. Mechanistically, Sema3A is predominantly expressed and significantly upregulated in MiVECs under pressure overload, and is efficiently released and delivered to the extracellular microenvironment through small extracellular vesicles (sEVs) with surface-attached Sema3A. Endothelial-specific Sema3A knockdown mice have been established as an in vivo model to investigate pressure overload-mediated cardiac microvascular rarefaction and cardiac fibrosis.

ADVANCED SCIENCE (2023)

Add to Collection

Article Peripheral Vascular Disease

Loss of ADAM15 Exacerbates Transition to Decompensated Myocardial Hypertrophy and Dilation Through Activation of the Calcineurin Pathway

Preetinder K. K. Aujla, Mei Hu, Bridgette Hartley, Joshua W. W. Kranrod, Anissa Viveiros, Tolga Kilic, Caroline A. A. Owen, Gavin Y. Y. Oudit, John M. M. Seubert, Olivier Julien, Zamaneh Kassiri

Summary: ADAM15 plays a role in suppressing myocardial hypertrophy in pressure overload cardiomyopathy by regulating the interaction between integrins and laminin, as well as the calcineurin pathway. Loss of ADAM15 leads to worsened hypertrophy and dilation in a mouse model of cardiomyopathy. This study provides new insights into the pathogenesis of cardiomyopathies.

HYPERTENSION (2023)

Add to Collection

Article Oncology

VEGF-C/VEGFR-3 axis protects against pressure-overload induced cardiac dysfunction through regulation of lymphangiogenesis

Qiu-Yue Lin, Yun-Long Zhang, Jie Bai, Jin-Qiu Liu, Hui-Hua Li

Summary: The study demonstrated that upregulation of cardiac lymphangiogenesis and reduced protein expression of VEGF-C and VEGFR-3 in failing hearts can lead to adverse effects such as cardiac edema, hypertrophy, fibrosis, apoptosis, inflammation, and dysfunction. Activation of the VEGF-C-VEGFR-3 axis may have a protective effect during the transition from cardiac hypertrophy to heart failure and targeted stimulation of cardiac lymphangiogenesis could be a potential therapeutic approach for hypertrophic heart diseases.

CLINICAL AND TRANSLATIONAL MEDICINE (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Dual-specificity Phosphatase 9 protects against Cardiac Hypertrophy by targeting ASK1

Lang Jiang, Lingyun Ren, Xin Guo, Jing Zhao, Hao Zhang, Shanshan Chen, Sheng Le, Hao Liu, Ping Ye, Manhua Chen, Jiahong Xia

Summary: The study revealed that DUSP9 plays a crucial role in cardiac hypertrophy, alleviating it by repressing ASK1, making it a promising prospective target for treating cardiac hypertrophy.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Ventricular TLR4 Levels Abrogate TLR2-Mediated Adverse Cardiac Remodeling upon Pressure Overload in Mice

Elise L. Kessler, Jiong-Wei Wang, Bart Kok, Maike A. Brans, Angelique Nederlof, Leonie van Stuijvenberg, Chenyuan Huang, Aryan Vink, Fatih Arslan, Igor R. Efimov, Carolyn S. P. Lam, Marc A. Vos, Dominique P. de Kleijn, Magda S. C. Fontes, Toon A. B. van Veen

Summary: Deficiency of TLR2 alleviates adverse cardiac remodeling caused by chronic pressure overload, with TLR2 and TLR4 both contributing to this process. The findings provide insights into potential therapeutic targets for preventing or intervening in cardiac diseases.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Article Multidisciplinary Sciences

Surgically Induced Cardiac Volume Overload by Aortic Regurgitation in Mouse

Jian Wu, Shijun Wang, Le Kang, Chunjie Yang, Jianguo Jia, Xingxu Wang, Ge Wei, Xuan Li, Jieyun You, Yunzeng Zou

Summary: This article describes a surgically induced mouse model of AR, which can be used reliably to study the molecular mechanisms and therapeutic targets of volume overload cardiomyopathy.

JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2022)

Add to Collection

Article Biochemistry & Molecular Biology

SAA1 deficiency alleviates cardiac remodeling by inhibiting NF-κB/p38/JNK and TGFβ/Smad pathways

Yusha Xiao, Lihua Ni, Hongjie Shi, Kang Yang, Jianguo Yang, Jinping Zhao, Jinping Liu, Pengcheng Luo

Summary: Heart failure (HF) is the end stage of many cardiovascular diseases, and cardiac remodeling is the main pathophysiological process leading to cardiac function deterioration in HF patients. Inflammation plays a crucial role in stimulating myocardial remodeling, which is significantly related to patient prognosis. SAA1, a lipid-binding protein involved in inflammation, has rarely been studied in the heart. This research aimed to investigate the role of SAA1 in cardiac remodeling using SAA1-deficient and wild-type mice. The results showed that SAA1 deficiency hindered cardiac fibrosis after 8 weeks of transverse aortic banding, but did not significantly affect cardiomyocyte hypertrophy. Additionally, SAA1 deficiency had no significant effect on cardiac fibrosis and hypertrophy in the sham group.

FASEB JOURNAL (2023)

Add to Collection

Article Medicine, General & Internal

Quantification of fibroblast growth factor 23 and N-terminal pro-B-type natriuretic peptide to identify patients with atrial fibrillation using a high-throughput platform: A validation study

Winnie Chua, Jonathan P. Law, Victor R. Cardoso, Yanish Purmah, Georgiana Neculau, Muhammad Jawad-Ul-Qamar, Kalisha Russell, Ashley Turner, Samantha P. Tull, Frantisek Nehaj, Paul Brady, Peter Kastner, Andre Ziegler, Georgios V. Gkoutos, Davor Pavlovic, Charles J. Ferro, Paulus Kirchhof, Larissa Fabritz

Summary: This study validated the reliability of an AF model using standardized, high-throughput, high-sensitivity biomarker assays. The results indicate that elevated NT-proBNP and FGF23, combined with age, sex, and BMI, can accurately identify patients with AF.

PLOS MEDICINE (2021)

Add to Collection

Article Neurosciences

Resting cardiac sympathetic firing frequencies suppress terminal norepinephrine transporter uptake

Lily L. Cao, Janice M. Marshall, Larissa Fabritz, Keith L. Brain

Summary: The study reveals that sympathetic neuronal activity can influence the function of NET, with higher frequencies leading to more significant suppression. Moreover, high concentrations of exogenous NE can abolish NET reuptake, affecting transport processes.

AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Coronary microvascular dysfunction is associated with degree of anaemia in end-stage renal disease

Ashwin Radhakrishnan, Luke C. Pickup, Anna M. Price, Jonathan P. Law, Kirsty C. McGee, Larissa Fabritz, Roxy Senior, Richard P. Steeds, Charles J. Ferro, Jonathan N. Townend

Summary: CMD is common in ESRD kidney transplant candidates despite the absence of traditional risk factors. Anemia may play a role in microvascular dysfunction in this population, as demonstrated by a positive correlation between hemoglobin levels and CFVR. Further investigation is warranted to explore the relationship between anemia and CMD.

BMC CARDIOVASCULAR DISORDERS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Cellular Mechanisms of the Anti-Arrhythmic Effect of Cardiac PDE2 Overexpression

Michael Wagner, Mirna S. Sadek, Nataliya Dybkova, Fleur E. Mason, Johann Klehr, Rebecca Firneburg, Eleder Cachorro, Kurt Richter, Erik Klapproth, Stephan R. Kuenzel, Kristina Lorenz, Jordi Heijman, Dobromir Dobrev, Ali El-Armouche, Samuel Sossalla, Susanne Kaemmerer

Summary: The study found that overexpression of PDE2 can reduce the likelihood of ventricular arrhythmia, mainly by preventing the increase of cellular triggers mediated by Epac and CaMKII, indicating that activating myocardial PDE2 may be a novel intracellular antiarrhythmic therapeutic strategy in heart failure.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Trends in the pharmacological management of atrial fibrillation in UK general practice 2008-2018

Katherine Phillips, Anuradhaa Subramanian, G. Neil Thomas, Nazish Khan, Joht Singh Chandan, Paul Brady, Tom Marshall, Krishnarajah Nirantharakumar, Larissa Fabritz, Nicola Jaime Adderley

Summary: Between 2008 and 2018, there was an increase in the proportion of AF patients prescribed anticoagulants, driven by the use of non-vitamin K antagonist anticoagulants. The prescription rate for rate control drugs remained constant, while there was a decline in GP prescribing rates for rhythm control drugs.

HEART (2022)

Add to Collection

Article Biochemistry & Molecular Biology

The Influence of VE-Cadherin on Adhesion and Incorporation of Breast Cancer Cells into Vascular Endothelium

Thomas Brock, Elisabeth Boudriot, Anke Klawitter, Marianne Grosser, Trang T. P. Nguyen, Sindy Giebe, Erik Klapproth, Achim Temme, Ali El-Armouche, Georg Breier

Summary: VE-cadherin enhances the adhesion of breast cancer cells to endothelial cells but does not affect their transmigration, indicating that cancer cell adhesion and incorporation are distinct processes governed by different molecular mechanisms.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Interactions Between Atrial Fibrillation and Natriuretic Peptide in Predicting Heart Failure Hospitalization or Cardiovascular Death

Paul F. Brady, Winnie Chua, Frantisek Nehaj, Derek L. Connolly, Alya Khashaba, Yanish J. Purmah, Muhammad J. Ul-Qamar, Mark R. Thomas, Chetan Varma, Renate B. Schnabel, Tanja Zeller, Larissa Fabritz, Paulus F. Kirchhof

Summary: This study found that elevated NT-proBNP concentrations predict future heart failure events in patients with atrial fibrillation, regardless of the presence of heart failure.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Increased atrial effectiveness of flecainide conferred by altered biophysical properties of sodium channels

Sian O'Brien, Andrew P. P. Holmes, Daniel M. M. Johnson, Christopher O'Shea, Molly O'Reilly, Adelisa Avezzu, Jasmeet S. S. Reyat, Amelia W. W. Hall, Clara Apicella, Patrick T. T. Ellinor, Steven Niederer, Nathan R. R. Tucker, Larissa Fabritz, Paulus Kirchhof, Davor Pavlovic, S. Nashitha Kabir

Summary: Atrial fibrillation is a major cause of stroke and heart failure in the elderly, and sodium channel blockers appear to have a relatively low risk of ventricular pro-arrhythmia in patients with this condition. The study found intrinsic differences between atrial and ventricular sodium currents, which may explain the reduced risk in atrial cells.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2022)

Add to Collection

Article Multidisciplinary Sciences

High resolution optical mapping of cardiac electrophysiology in pre-clinical models

Christopher O'Shea, James Winter, S. Nashitha Kabir, Molly O'Reilly, Simon P. Wells, Olivia Baines, Laura C. Sommerfeld, Joao Correia, Ming Lei, Paulus Kirchhof, Andrew P. Holmes, Larissa Fabritz, Kashif Rajpoot, Davor Pavlovic

Summary: Optical mapping is a widely used technique in pre-clinical cardiac research, allowing for efficient study of cardiac electrophysiology and the effects of interventions on arrhythmia.

SCIENTIFIC DATA (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Remote Design of a Smartphone and Wearable Detected Atrial Arrhythmia in Older Adults Case Finding Study: Smart in OAC - AFNET 9

Larissa Fabritz, D. Connolly, E. Czarnecki, D. Dudek, A. Zlahoda-Huzior, E. Guasch, D. Haase, T. Huebner, K. Jolly, P. Kirchhof, Ulrich Schotten, Antonia Zapf, Renate B. Schnabel

Summary: Smart in OAC - AFNET 9 study aims to evaluate the screening efficacy of PPG-detected atrial arrhythmias using wearable devices in older adults in Europe, and estimate the prevalence of atrial arrhythmias in an unselected population of older adults.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET/EHRA consensus conference

Renate B. Schnabel, Elena Andreassi Marinelli, Elena Arbelo, Giuseppe Boriani, Serge Boveda, Claire M. Buckley, A. John Camm, Barbara Casadei, Winnie Chua, Nikolaos Dagres, Mirko de Melis, Lien Desteghe, Soren Zoga Diederichsen, David Duncker, Lars Eckardt, Christoph Eisert, Daniel Engler, Larissa Fabritz, Ben Freedman, Ludovic Gillet, Andreas Goette, Eduard Guasch, Jesper Hastrup Svendsen, Stephane N. Hatem, Karl Georg Haeusler, Jeff S. Healey, Hein Heidbuchel, Gerhard Hindricks, F. D. Richard Hobbs, Thomas Huebner, Dipak Kotecha, Michael Krekler, Christophe Leclercq, Thorsten Lewalter, Honghuang Lin, Dominik Linz, Gregory Y. H. Lip, Maja Lisa Lochen, Wim Lucassen, Katarzyna Malaczynska-Rajpold, Steffen Massberg, Jose L. Merino, Ralf Meyer, Lluis Mont, Michael C. Myers, Lis Neubeck, Teemu Niiranen, Michael Oeff, Jonas Oldgren, Tatjana S. Potpara, George Psaroudakis, Helmut Purerfellner, Ursula Ravens, Michiel Rienstra, Lena Rivard, Daniel Scherr, Ulrich Schotten, Dipen Shah, Moritz F. Sinner, Rudiger Smolnik, Gerhard Steinbeck, Daniel Steven, Emma Svennberg, Dierk Thomas, Mellanie True Hills, Isabelle C. van Gelder, Burcu Vardar, Elena Pala, Reza Wakili, Karl Wegscheider, Mattias Wieloch, Stephan Willems, Henning Witt, Andre Ziegler, Matthias Daniel Zink, Paulus Kirchhof

Summary: This article summarizes the key outcomes of the 8th AFNET/EHRA Consensus Conference, which was held in Hamburg in October 2021 and attended by 83 international experts. The consensus paper highlights new evidence-based approaches to improve care for patients with atrial fibrillation (AF), including population-based screening, evolving management strategies, atrial cardiomyopathy characterization, cognitive function assessment, and the role of artificial intelligence (AI).

EUROPACE (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Eligibility for early rhythm control in patients with atrial fibrillation in the UK Biobank

Shinwan Kany, Victor Roth Cardoso, Laura Bravo, John A. Williams, Renate Schnabel, Larissa Fabritz, Georgios V. Gkoutos, Paulus Kirchhof

Summary: The study found that around 80% of participants diagnosed with AF in the UK population are eligible for early rhythm-control therapy. Early rhythm-control therapy was shown to be safe in routine care.

HEART (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Characterisation of patients referred to a tertiary-level inherited cardiac condition clinic with suspected arrhythmogenic right ventricular cardiomyopathy (ARVC)

A. Aljehani, T. Kew, S. Baig, H. Cox, L. C. Sommerfeld, B. Ensam, M. Kalla, R. P. Steeds, L. Fabritz

Summary: This study describes the initial presentation and cardiac phenotype of definite and non-definite ARVC patients. It found that patients in the definite ARVC group had more pronounced symptoms, more abnormal electrocardiographic and cardiac imaging features, and a higher incidence of major adverse cardiac events.

BMC CARDIOVASCULAR DISORDERS (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Familial atrial fibrillation mutation M1875T-SCN5A increases early sodium current and dampens the effect of flecainide

Molly O'Reilly, Laura C. Sommerfeld, C. O'Shea, S. Broadway-Stringer, S. Andaleeb, J. S. Reyat, S. N. Kabir, D. Stastny, A. Malinova, D. Delbue, L. Fortmueller, K. Gehmlich, D. Pavlovic, B. Skryabin, A. P. Holmes, P. Kirchhof, L. Fabritz

Summary: This study found that the point mutation M1875T in the SCN5A gene is associated with familial AF. A new mouse model was used to show that this mutation causes gain-of-function of the cardiac sodium channel, resulting in increased atrial excitability.

EUROPACE (2023)

Add to Collection

Article Multidisciplinary Sciences

An angiopoietin 2, FGF23, and BMP10 biomarker signature differentiates atrial fibrillation from other concomitant cardiovascular conditions

Winnie Chua, Victor R. Cardoso, Eduard Guasch, Moritz F. Sinner, Christoph Al-Taie, Paul Brady, Barbara Casadei, Harry J. G. M. Crijns, Elton A. M. P. Dudink, Stephane N. Hatem, Stefan Kaeaeb, Peter Kastner, Lluis Mont, Frantisek Nehaj, Yanish Purmah, Jasmeet S. Reyat, Ulrich Schotten, Laura C. Sommerfeld, Stef Zeemering, Andre Ziegler, Georgios V. Gkoutos, Paulus Kirchhof, Larissa Fabritz

Summary: Early detection of atrial fibrillation through the measurement of circulating biomarkers can reduce the risk of stroke, cardiovascular death, and heart failure.

SCIENTIFIC REPORTS (2023)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.